0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Join our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessFlorentia Dimitriou, Kenjiro Namikawa, Irene L. M. Reijers, Elizabeth I. Buchbinder, J. Soon, Anne Zaremba, Paweł Teterycz, Meghan J. Mooradian, Emma Armstrong, Yasuhiro Nakamura, Maria Grazia Vitale, Lena Tran, Xue Bai, Clara Allayous, S. Provent-Roy, Alice Indini, Prachi Bhave, Mohamad Farid, Katharina C. Kähler, Inderjit Mehmi, Victoria Atkinson, Oliver Klein, Connor J. Stonesifer, Farzana Y. Zaman, Andrew Haydon, Richard D. Carvajal, Omid Hamid, Reinhard Dummer, Axel Hauschild, Matteo S. Carlino, Mario Mandalà, Caroline Robert, Célèste Lebbé, Jun Guo, Douglas B. Johnson, Paolo A. Ascierto, Alexander N. Shoushtari, Ryan J. Sullivan, Bożena Cybulska-Stopa, Piotr Rutkowski, Lisa Zimmer, Shahneen Sandhu, Christian U. Blank, Serigne Lo, Alexander M. Menzies, Georgina V. Long (2022). Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study. , 33(9), DOI: https://doi.org/10.1016/j.annonc.2022.06.004.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2022
Authors
46
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1016/j.annonc.2022.06.004
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free AccessYes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaboration
